Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhuoyu Gu

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Journal of Cellular and Molecular Medicine|April 22, 2024
Development of m6A/m5C/m1A regulated lncRNA signature for prognostic prediction, personalized immune intervention and drug selection in LUADChao Ma, Zhuoyu Gu, Yang Yang
Current Medicinal Chemistry|April 29, 2026
Key Toxic Genes and Mechanisms of Di(2-ethylhexyl) Phthalate-Induced Non-Alcoholic Fatty Liver Disease: A Multi-Omics StudyXuemeng Zhao, Zhuoyu Gu, Jingya Yan
Frontiers in Pediatrics|July 21, 2023
Identification of five novel variants of <i>ADAR1</i> in dyschromatosis symmetrica hereditaria by next-generation sequencingQian Ma, Lingyi Che, Yibing Chen, et al.
Frontiers in Pharmacology|September 6, 2023
A novel defined risk signature of cuproptosis-related long non-coding RNA for predicting prognosis, immune infiltration, and immunotherapy response in lung adenocarcinomaChao Ma, Feng Li, Zhuoyu Gu, et al.
International Journal of Clinical and Experimental Pathology|October 15, 2015
Reverse correlation of Jab1 and Smad4 in PANC-1 cells involved in the pathogenesis of pancreatic cancerJun Li, Zhuoyu Gu, Siyuan Li, et al.
Aging|November 27, 2023
Crosstalk between copper homeostasis and cuproptosis reveals a lncRNA signature to prognosis prediction, immunotherapy personalization, and agent selection for patients with lung adenocarcinomaChao Ma, Zhuoyu Gu, Weizheng Ding, et al.
International Journal of Clinical and Experimental Pathology|May 15, 2015
Anti-tumor effect and mechanism of cyclooxygenase-2 inhibitor through matrix metalloproteinase 14 pathway in PANC-1 cellsSiyuan Li, Zhuoyu Gu, Zhiwei Xiao, et al.
Frontiers in Oncology|July 25, 2022
The hnRNPK/A1/R/U Complex Regulates Gene Transcription and Translation and is a Favorable Prognostic Biomarker for Human Colorectal AdenocarcinomaYixin Li, Hui Wang, Jiajia Wan, et al.
Frontiers in Pharmacology|March 6, 2023
Prognosis and personalized treatment prediction in lung adenocarcinoma: An <i>in silico</i> and <i>in vitro</i> strategy adopting cuproptosis related lncRNA towards precision oncologyChao Ma, Feng Li, Zhanfeng He, et al.
Respiratory Research|December 19, 2022
HNRNPC, a predictor of prognosis and immunotherapy response based on bioinformatics analysis, is related to proliferation and invasion of NSCLC cellsZhuoyu Gu, Yang Yang, Qian Ma, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Journal of Cellular and Molecular Medicine|April 22, 2024
Development of m6A/m5C/m1A regulated lncRNA signature for prognostic prediction, personalized immune intervention and drug selection in LUADChao Ma, Zhuoyu Gu, Yang Yang
Current Medicinal Chemistry|April 29, 2026
Key Toxic Genes and Mechanisms of Di(2-ethylhexyl) Phthalate-Induced Non-Alcoholic Fatty Liver Disease: A Multi-Omics StudyXuemeng Zhao, Zhuoyu Gu, Jingya Yan
Frontiers in Pediatrics|July 21, 2023
Identification of five novel variants of <i>ADAR1</i> in dyschromatosis symmetrica hereditaria by next-generation sequencingQian Ma, Lingyi Che, Yibing Chen, et al.
Frontiers in Pharmacology|September 6, 2023
A novel defined risk signature of cuproptosis-related long non-coding RNA for predicting prognosis, immune infiltration, and immunotherapy response in lung adenocarcinomaChao Ma, Feng Li, Zhuoyu Gu, et al.
International Journal of Clinical and Experimental Pathology|October 15, 2015
Reverse correlation of Jab1 and Smad4 in PANC-1 cells involved in the pathogenesis of pancreatic cancerJun Li, Zhuoyu Gu, Siyuan Li, et al.
Aging|November 27, 2023
Crosstalk between copper homeostasis and cuproptosis reveals a lncRNA signature to prognosis prediction, immunotherapy personalization, and agent selection for patients with lung adenocarcinomaChao Ma, Zhuoyu Gu, Weizheng Ding, et al.
International Journal of Clinical and Experimental Pathology|May 15, 2015
Anti-tumor effect and mechanism of cyclooxygenase-2 inhibitor through matrix metalloproteinase 14 pathway in PANC-1 cellsSiyuan Li, Zhuoyu Gu, Zhiwei Xiao, et al.
Frontiers in Oncology|July 25, 2022
The hnRNPK/A1/R/U Complex Regulates Gene Transcription and Translation and is a Favorable Prognostic Biomarker for Human Colorectal AdenocarcinomaYixin Li, Hui Wang, Jiajia Wan, et al.
Frontiers in Pharmacology|March 6, 2023
Prognosis and personalized treatment prediction in lung adenocarcinoma: An <i>in silico</i> and <i>in vitro</i> strategy adopting cuproptosis related lncRNA towards precision oncologyChao Ma, Feng Li, Zhanfeng He, et al.
Respiratory Research|December 19, 2022
HNRNPC, a predictor of prognosis and immunotherapy response based on bioinformatics analysis, is related to proliferation and invasion of NSCLC cellsZhuoyu Gu, Yang Yang, Qian Ma, et al.
Pageof 4